Yes, hi. Thanks for the opportunity again. So on Bepirovirsen, which is the hepatitis product, when do you expect an approval there?
Okay. And in the trials, how many patients got completely cured on account of the trial?
Questions across 8 calls
Vishal Manchanda
Firm not listed in source transcripts
GlaxoSmithKline Pharmaceuticals Limited
Lupin Limited
On the Albuterol inhaler market , wanted to check whether you expect any adverse impact on account of the GSK launch. So, they are supposed to launch a green inhaler around third quarter of this financial year. Do you think the other Albuterol inhalers on the market will see an adverse impact?
Since you are working on a green propellant too, will you need to launch as a brand?
Can you share whether you would have filed generic Semaglutide in Brazil?
And second on biosimilars, can you quantify as to like what do you would be annually spending on biosimilar development and other operating costs? So are we burning money there right now?
Biocon Limited
This is Vishal from Systematix. Can you break up your biosimilar sales between U.S., emerging U.S., Europe and the rest of world?
And which would be our largest product as of now within the biosimilar portfolio?
Hi good morning. This is Vishal Manchanda, Systematix Institutional Equities. On adalimumab, could you give a timeline as to when the regulatory process and tech transfer can get completed and broadly, the rationale for doing this deal?
And just one more on Aflibercept. Just wanted a clarification whether we own 100% of the rights here or we'll have to give out some profit share to J&J or Momenta?
Zydus Lifesciences Limited
Thanks for the opportunity. Hope I'm audible.
I have a question on CUTX-101. So, basically wanted to understand whether we have been able to qualify for a screening test here? So , kind of , is there screening test approved for ne o- natal?
Poly Medicure Limited
So that is where you would be directly reaching through your own sales force.
Understood. And again, on this on the domestic business, like if you could share as to what which one would be your top 3 portfolio products and what would be their contribution?
Sun Pharmaceutical Industries Limited
Hi, good morning and thanks for the opportunity. On Nexplanon, would you kind of want to rate this in terms of the complexity by your experience like would this be the most complex generic and would you expect a generic to come in by 2030 when the patent expires?
But would this be one of the most complex or like comparing it to NuvaRing, would this be much more complex than that?